We evaluated the utility of blood flow velocity measurements by transcranial Doppler ultrasonography as a tool to indirectly measure cerebral perfusion during cardiopulmonary bypass.
B
rain injury is one of the most serious complications of cardiac surgery under cardiopulmonary bypass (CPB). 1 Continuous monitoring of cerebral blood flow (CBF) during CPB seems to be of great value since cerebral hypoperfusion or hyperperfusion is suggested as a possible etiologic factor in brain injury. 2 However, measurement of CBF by the isotope washout technique 3 is too invasive, expensive, and timeconsuming to become a popular monitoring method during CPB.
Transcranial Doppler ultrasonography (TCD) can measure the blood flow velocity in intracranial basal vessels by using a 2-MHz pulsed wave that allows sufficient ultrasound to penetrate the cranial bone. 4 Several reports have indicated a close relation between changes in CBF and changes in blood velocity measured by TCD in humans or animals. 512 Thus, changes in blood flow velocity continuously measured by TCD have been shown to help in evaluating CBF and maintaining an adequate cerebral perfusion in some situations in which other clinical parameters cannot be assessed.
In the present study simultaneous measurements of blood flow velocity in the middle cerebral artery (MCA velocity) by TCD and physiological variables during hypothermic CPB were performed to evaluate cerebral
Subjects and Methods

Patients and Anesthesia
After approval from the Hospital Committee on Human Research and after obtaining consent, 18 patients (mean±SD age, 49.8 ±18.2 years) undergoing elective open heart procedures were subjected to this study. Patients with clinical evidence of cerebrovascular disease or uncontrolled hypertension were excluded from this study. All patients were premedicated with morphine sulfate 0.1 to 0.2 mg/kg IM and scopolamine 0.015 mg/kg IM 90 minutes before the start of the operation. Anesthesia was induced and maintained with fentanyl 80±15 fig/kg, and ventilation was controlled with an air/oxygen mixture to maintain normocarbia. Diazepam 0.2 mg/kg was administered immediately before starting CPB. No anesthetics were administered during CPB.
After induction, a 4F, 13-cm-long, double-lumen catheter (Arrow International Inc, Reading, Pa) was inserted into the right jugular venous bulb for blood sampling and continuous monitoring of jugular venous bulb pressure. Postoperative confirmation of the appropriate location of the catheter tip was obtained by a plain skull x-ray. Rectal, esophageal, and nasopharyngeal temperatures were continuously monitored. During hypothermic CPB, pH and Paco? were maintained at 7.40 and 40 mm Hg, respectively, as measured in a blood gas analyzer at 37°C (alpha-stat strategy 13 ). Blood samples were analyzed with a blood gas analyzer (ABL 300, Radiometer, Copenhagen, Denmark) and a hemoximeter (OSM3, Radiometer). Sodium bicarbonate was given to maintain a base deficit of not greater than 4 mEq/L, measured at 37°C.
Measurement of Middle Cerebral Artery Velocity
The TCD Transpect II probe (Medasonics, Mountainview, Calif) was positioned over the right temporal bone window and anchored using a head harness so that the angle of insonation remained constant throughout the study. Doppler signals from the right middle cerebral artery (MCA) were identified and measured at a depth of 40 to 55 mm. Confirmation of signals from the MCA was performed by gate depth, direction of signals, and compression tests. 14 The shift frequency spectra of the Doppler signals were converted into velocity by fast Fourier transformation and displayed on a video monitor. The time/mean velocity of MCA blood flow for 4.27 seconds was continuously calculated by the equipment. However, some artifacts generated from electric instruments in the operating department made automatic, continuous measurements of time/mean velocity inaccurate, and the mean MCA velocity was therefore calculated from systolic and diastolic velocities using the following formula: Mean MCA Velocity=Diastolic Velocity+(Systolic Velocity-Diastolic Velocity)/3.
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Before skin incision, after establishment of steady-state ventilation, three consecutive baseline measurements of the time/mean velocity in MCA (MCA velocity) were performed over 3 minutes at a PacOj of 38 to 42 mm Hg. The average of these three baseline measurements of MCA velocity was taken to represent the control value.
Measured Variables
Middle cerebral artery velocity, cerebral perfusion pressure (defined as MABP minus jugular bulb venous pressure), pump flow, and nasopharyngeal temperature were measured every 15 minutes. Arterial oxygen tension, Paco^, arterial oxygen content, arterial hematocrit, jugular bulb venous oxygen tension, carbon dioxide tension, and oxygen content were measured at intervals of 30 to 60 minutes during the study. Because MCA velocity varied considerably from patient to patient, MCA velocity was also expressed as a relative value to the control (relative MCA velocity). Cerebral oxygen extraction ratio (defined as difference between arterial and jugular bulb venous oxygen content divided by arterial oxygen content) and an original index of cerebral metabolic rate for oxygen, the modified cerebral metabolic rate for oxygen (modified CMRO 2 , defined as difference between arterial and jugular bulb venous oxygen content multiplied by relative MCA velocity), were calculated.
Statistical Analysis
During the study there were 566 measurements of MCA velocity and physiological variables, 157 paired analyses of arterial and jugular venous bulb blood gas, and 60 analyses of arterial blood gas. Control MCA velocity was obtained at a PacOj of 39.7±2.7 mm Hg (mean±SD).
All variables obtained throughout the study were divided into the following seven periods according to sampling time: prebypass, partial bypass 8 (before aortic cross-clamp), total bypass 8 (before aortic cross-clamp), aortic cross-clamp, total bypass* (after aortic cross-clamp), partial bypass* (after aortic cross-clamp), and postbypass. Variables during the postbypass period were obtained within 30 minutes after weaning from CPB. Multiple comparisons between each period were made using a one-way ANOVA with post hoc Fisher's protected least significant difference test. A simple linear regression technique was performed between variables. Further, in stable hypothermic CPB (during aortic cross-clamp), multiple stepwise linear regression analysis using the methods of ordinary least squares was'regressed on 10 variables (cerebral perfusion pressure, pump flow, nasopharyngeal temperature, hematocrit, PacOj, jugular bulb venous oxygen tension, difference between arterial and jugular bulb venous oxygen content, modified CMRO 2 , cerebral oxygen extraction ratio, and duration of aortic cross-clamp) against relative MCA velocity for the identification of significant variables. Significance was assumed for a value of P<.05 in all comparisons. All data were expressed as mean±SD.
Results
All patients survived the operation without clinical evidence of cerebral complications. Table 1 shows surgical procedures and demographic and CPB data. There was a significant (r=.576, i'<.0005) linear relation between relative MCA velocity and nasopharyngeal temperature during surgery (Fig 1) . There was a highly significant (r=.756, /><.0005) exponential relation between modified CMRO 2 and nasopharyngeal temperature during cooling (Fig 2) . The temperature coefficient (Q 10 ) for modified CMRO 2 between 37°C and 27°C was 2.7±1.4 (mean±SD, n=10) during cooling. There was a highly significant linear relation (r=.639, i'<.0005) between jugular bulb venous oxygen tension and modified CMRO 2 during surgery (Fig 3) . Table 2 
Discussion
Transcranial Doppler ultrasonography cannot measure flow in a vessel but can measure blood flow velocity. Because blood flow through a vessel is equal to the mean velocity multiplied by the cross-sectional area of the vessels, measurements of both velocity and segment vessel diameter are essentially needed to estimate blood flow. Estimation of CBF based on blood flow velocity measurements alone, therefore, represents a risky shortcut. 16 However, several lines of evidence have shown that cerebral basal arteries are relatively constant in their diameter during changes in blood pressure, and that small arterioles play an important role in keeping CBF (pressure-flow autoregulation) constant by changing their calibers through the vasomotor action of smooth muscle. Experimental studies have shown that the brain parenchymal small arterioles (with diameters <40 ixm) mainly dilate against changes in blood pressure, whereas arterioles with diameters of 322 /jcm increase their calibers only minimally. 1719 If these findings are extrapolated to the human MCA, which is larger than 1000 /xm in diameter, it is conceivable that the MCA may not change its diameter during changes in blood pressure. Thus, we can estimate the changes in CBF by measuring changes in MCA velocity (relative MCA velocity) without simultaneous measurement of cross-sectional area.
Hypocarbia is well known to cause cerebral vasoconstriction, while hypercarbia causes vasodilatation. However, Huber and Handa 20 showed that the calibers of the basal large arteries remain constant during changes in Paco 2 . Moreover, Markwalder et al 21 found the same CO 2 reactivity in changes of MCA velocity and CBF in response to changes of end-tidal PCO2 in the range of 22 to 50 mm Hg. They indicated that the vasomotor action in response to Paco 2 is confined to small arterioles but not to cerebral basal arteries. These findings demonstrate the relatively constant diameter of the MCA during changes in Pacc^.
Furthermore, several studies indicate that changes in blood flow velocity are well correlated with changes in CBF in humans or animals. So far, a significant correlation between them has been shown by Bishop There have been two options for blood gas management during hypothermic CPB. One option, termed pH-stat strategy, maintains PacO2 and pH at 40 mm Hg and 7.50, respectively, after correction for body temperature (temperature corrected). The alternative, alphastat strategy, maintains Paco 2 and pH at 40 mm Hg and 7.40, respectively, as measured in the blood gas analyzer at 37°C (temperature noncorrected). Blood gas management with pH-stat strategy results in increased Paco2 and CBF over cerebral metabolic demand. Therefore, both the coupling of CBF/CMRO 2 (metabolic autoregulation) and flow-pressure autoregulation might not be preserved in pH-stat. With alpha-stat strategy, CBF is dependent on CMRO 2 but not cerebral perfusion pressure. Both metabolic and pressure-flow autoregulation are preserved during moderate hypothermic CPB. 22 In the present study both MCA velocity and relative MCA velocity significantly decreased in correlation with nasopharyngeal temperature during hypothermic CPB. This observation is consistent with the recent study by Hillier et al, 23 who reported a close correlation (r=.78) between relative blood flow velocity and temperature in neonates or infants undergoing cardiac surgery. In contrast, Lundar et al 24 reported that MCA velocity measured by TCD markedly increased in 10 of 11 patients (range, 80% to 300% of the prebypass values) during stable hypothermic CPB. Von Reutern et al 25 also reported an increase in MCA velocity during stable CPB (127% of the prebypass values). These quite divergent observations of changes in MCA velocity may be explained on the basis of different blood gas management during hypothermic CPB. The alpha-stat strategy was applied in both Hillier et al 23 and the present study, whereas Lundar et al 24 and Von Reutern et al 25 applied 22 An index of modified CMRO 2 (defined as difference between arterial and jugular bulb venous oxygen contents multiplied by relative MCA velocity) was calculated to estimate CMRO 2 . There was a close correlation (r=.756) between modified CMRO 2 and nasopharyngeal temperature during cooling. There was also a close relation (r=.639) between modified CMRO 2 and jugular bulb venous oxygen tension during surgery. The mean Q 10 in the present study (2.7) is also comparable to that (2.8) in the study of Kent and Peirce. 26 These findings suggest that modified CMRO 2 is a valuable index for evaluation of changes in CMRO 2 .
In regard to variables affecting relative MCA velocity during stable hypothennic CPB, nasopharyngeal temperature and Pacc^ were found to be significant determinants for relative MCA velocity as demonstrated by multiple stepwise linear regression technique in the present study. These two determinants are consistent with the study by Govier et al, 27 who found that nasopharyngeal temperature and Pacc^ were the only factors that significantly influenced regional CBF measured by the xenon-131 clearance method during nonpulsatile hypothennic CPB. These findings indicate that the physiological variables that correlate with regional CBF are the same physiological variables that also correlate with relative MCA velocity during hypothermic CPB.
In summary, we demonstrated that relative MCA velocity correlated well with nasopharyngeal temperature but not with cerebral perfusion pressure, and that the coupling of relative MCA velocity and modified CMRO 2 remained intact under blood gas management with alpha-stat during moderate hypothennic CPB. Q 10 obtained from the present data was almost comparable with that from other studies. We also demonstrated that the determinants of regional CBF were the same as the determinants of relative MCA velocity during stable hypothennic CPB.
Thus, changes in CBF and CMRO 2 during hypothermic CPB can be evaluated by the measurement of relative MCA velocity and modified CMRO 2 with simplicity and minimum invasiveness.
